Physician profile
Thomas A Dwyer
NPI 1972678027
$3,428.10
in general payments reported to CMS, 2019-2025
16 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,970 · 2020: $115 · 2021: $234 · 2022: $509 · 2023: $157 · 2024: $179 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,486.29 | 2019-2025 | Mako, Triathlon, Insignia |
| Ossio INC | $200.83 | 2022 | |
| Smith+Nephew, INC. | $191.86 | 2019 | |
| Zimmer Biomet Holdings, INC. | $171.82 | 2020-2025 | Quattro, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $96.28 | 2019 | |
| Baxter Healthcare | $42.79 | 2023 | Floseal |
| Terumo Bct, INC. | $42.28 | 2019 | |
| Bioventus LLC | $30.90 | 2019 | |
| Pacira Therapeutics, INC. | $29.59 | 2019 | |
| Nevro Corp. | $28.08 | 2019 | |
| Boston Scientific Corporation | $26.44 | 2025 | General - Pain Management |
| Ossur Americas, INC. | $19.88 | 2024 | Miami J |
| Fx Shoulder Solutions, INC | $19.73 | 2020 | |
| Dynasplint Systems INC. | $18.38 | 2024 | Dynasplint |
| Amgen INC. | $17.62 | 2025 | Krystexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $5.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dwyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.